EV/EBITDA
-13.85
+0.29+2.05%
Fri, 07 Feb 2025 21:03:20 GMT
Summary
- As of February 8, 2025, TBPH EV/EBITDA is -13.85, with a rise of +0.29 (+2.05%) during the most recent trading day.
- TBPH EV/EBITDA is now -949.24% below its all-time high of -1.32.
Performance
TBPH EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TBPH EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.0% | -2.1% | -2.2% |
| 1 m1 month | -0.6% | +0.5% | +0.5% |
| 3 m3 months | - | - | +6.3% |
| 6 m6 months | - | - | +18.8% |
| ytdytd | +1.1% | -1.1% | -1.2% |
| 1 y1 year | - | - | +9.4% |
| 5 y5 years | -28.1% | -78.2% | -69.7% |
TBPH EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -9.8% | -15.51 | +10.7% | |
| 3 m | 3-month | -12.62 | -9.8% | -15.51 | +10.7% |
| 6 m | 6-month | -11.73 | -18.1% | -15.51 | +10.7% |
| 1 y | 1-year | -11.73 | -18.1% | -15.51 | +10.7% |
| 3 y | 3-year | -2.32 | -497.0% | -15.51 | +10.7% |
| 5 y | 5-year | -2.32 | -497.0% | -15.51 | +10.7% |
| alltime | all time | -1.32 | -949.2% | -15.51 | +10.7% |
Theravance Biopharma EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -13.85(-1.1%) |
| 2024 | -14.00(+134.9%) |
| 2022 | -5.96(-11.0%) |
| 2021 | -6.70(+10.9%) |
| 2020 | -6.04(-36.2%) |
| Date | Value |
|---|---|
| 2019 | -9.47(+33.9%) |
| 2018 | -7.07(+11.0%) |
| 2017 | -6.37(-28.2%) |
| 2016 | -8.87(+210.1%) |
| 2015 | -2.86(+66.3%) |
| 2014 | -1.72 |
FAQ
- What is Theravance Biopharma EV/EBITDA?
- What is the all time high EV/EBITDA for Theravance Biopharma?
- What is TBPH EV/EBITDA year-to-date change?
What is Theravance Biopharma EV/EBITDA?
The current EV/EBITDA of TBPH is -13.85
What is the all time high EV/EBITDA for Theravance Biopharma?
Theravance Biopharma all-time high EV/EBITDA is -1.32
What is TBPH EV/EBITDA year-to-date change?
Theravance Biopharma EV/EBITDA has changed by +0.15 (+1.07%) since the beginning of the year